For physicians
Our genetic tests help to identify the most relevant targeted treatment, immunotherapies based on patient’s genetic profile.
Identification of biomarkers with potential to predict therapeutic response on various targeted therapies.
COMPREHENSIVE GENOMIC PROFILING
Comprehensive profiling of solid tumours provides a unique opportunity to identify anticancer therapy, designed for selected patient, based on the specific caracteristics of their tumor. The advent of next-generation sequencing (NGS) technology such as next-generation sequencing (NGS), has enabled industry and academia to provide products and services that enable physicians to understand the therapeutic implications of patient data, based on computational analysis of clinical and molecular knowledge in real time.
Medical report ONCOGENE® comprises:
1
The description of clinically detectable significant mutations in the context of the patient's disease.
2
Potentially significant information about clinical and scientific research of the detected mutations.
3
Potentially effective and ineffective drugs, based on analysis of the detected mutations of patient's tumour.
4
Drugs with potential side effects based on analysis of the pharmacogenomics markers.
5
Other relevant information from external databases: COSMIC (Catalogue of Somatic Mutations in Cancer); dbSNP (Single Nucleotide Polymorphism Database); NCCN (National Comprehensive Cancer Network); Drug Label Information.
ADDITIONAL RESOURCES
We are offering the most comprehensive suite of genetic testing options, based on each patient's needs. Talk to your doctor about whether genetic testing is right for you.
CONTACT US
Ask any question you are
interested in.
Address
116, Bucuresti str.
Chisinău, Moldova
Our doors are open
Monday - Friday
9:00 - 18:00
Saturday - Sunday
closed